The relationship between VEGF levels and HER2/neu tumor expression was studied in IBC patients, revealing that VEGF content was 1.51 times higher in the HER2/neu positive tumor group compared to the HER2/neu negative group (r=0.36, p<0.05). The gene discussed is VEGFA; the disease is inflammatory breast carcinoma.